231 related articles for article (PubMed ID: 35315791)
1. A suppressor of dioxygenase inhibition in a yeast model of SDH deficiency.
Beimers W; Braun M; Schwinefus K; Pearson K; Wilbanks B; Maher LJ
Endocr Relat Cancer; 2022 May; 29(6):345-358. PubMed ID: 35315791
[TBL] [Abstract][Full Text] [Related]
2. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.
Smith EH; Janknecht R; Maher LJ
Hum Mol Genet; 2007 Dec; 16(24):3136-48. PubMed ID: 17884808
[TBL] [Abstract][Full Text] [Related]
3. Succinate dehydrogenase/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammation.
Chen X; Sunkel B; Wang M; Kang S; Wang T; Gnanaprakasam JNR; Liu L; Cassel TA; Scott DA; Muñoz-Cabello AM; Lopez-Barneo J; Yang J; Lane AN; Xin G; Stanton BZ; Fan TW; Wang R
Sci Immunol; 2022 Apr; 7(70):eabm8161. PubMed ID: 35486677
[TBL] [Abstract][Full Text] [Related]
4. MITOCHONDRIA: Succinate dehydrogenase subunit B-associated phaeochromocytoma and paraganglioma.
Dona M; Neijman K; Timmers HJLM
Int J Biochem Cell Biol; 2021 May; 134():105949. PubMed ID: 33609747
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening for growth inhibitors using a yeast model of familial paraganglioma.
Bancos I; Bida JP; Tian D; Bundrick M; John K; Holte MN; Her YF; Evans D; Saenz DT; Poeschla EM; Hook D; Georg G; Maher LJ
PLoS One; 2013; 8(2):e56827. PubMed ID: 23451094
[TBL] [Abstract][Full Text] [Related]
6. Oxygen concentration controls epigenetic effects in models of familial paraganglioma.
Her YF; Nelson-Holte M; Maher LJ
PLoS One; 2015; 10(5):e0127471. PubMed ID: 25985299
[TBL] [Abstract][Full Text] [Related]
7. Model systems in SDHx-related pheochromocytoma/paraganglioma.
Takács-Vellai K; Farkas Z; Ősz F; Stewart GW
Cancer Metastasis Rev; 2021 Dec; 40(4):1177-1201. PubMed ID: 34957538
[TBL] [Abstract][Full Text] [Related]
8. Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors.
Zhao Y; Feng F; Guo QH; Wang YP; Zhao R
World J Gastroenterol; 2020 Sep; 26(34):5074-5089. PubMed ID: 32982110
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of the oncometabolite succinate in SDHx-mutation carriers.
Eijkelenkamp K; Osinga TE; Links TP; van der Horst-Schrivers ANA
Clin Genet; 2020 Jan; 97(1):39-53. PubMed ID: 30977114
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of tumorigenesis caused by succinate dehydrogenase defect.
Moosavi B; Zhu XL; Yang WC; Yang GF
Eur J Cell Biol; 2020 Jan; 99(1):151057. PubMed ID: 31810635
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
[TBL] [Abstract][Full Text] [Related]
12. Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism.
Lussey-Lepoutre C; Hollinshead KE; Ludwig C; Menara M; Morin A; Castro-Vega LJ; Parker SJ; Janin M; Martinelli C; Ottolenghi C; Metallo C; Gimenez-Roqueplo AP; Favier J; Tennant DA
Nat Commun; 2015 Nov; 6():8784. PubMed ID: 26522426
[TBL] [Abstract][Full Text] [Related]
13. Instability of succinate dehydrogenase in SDHD polymorphism connects reactive oxygen species production to nuclear and mitochondrial genomic mutations in yeast.
Chang YL; Hsieh MH; Chang WW; Wang HY; Lin MC; Wang CP; Lou PJ; Teng SC
Antioxid Redox Signal; 2015 Mar; 22(7):587-602. PubMed ID: 25328978
[TBL] [Abstract][Full Text] [Related]
14. β-Cell Succinate Dehydrogenase Deficiency Triggers Metabolic Dysfunction and Insulinopenic Diabetes.
Lee S; Xu H; Van Vleck A; Mawla AM; Li AM; Ye J; Huising MO; Annes JP
Diabetes; 2022 Jul; 71(7):1439-1453. PubMed ID: 35472723
[TBL] [Abstract][Full Text] [Related]
15. [Succinate dehydrogenase in cancer].
Moog S; Favier J
Med Sci (Paris); 2022 Mar; 38(3):255-262. PubMed ID: 35333162
[TBL] [Abstract][Full Text] [Related]
16. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.
Hao HX; Khalimonchuk O; Schraders M; Dephoure N; Bayley JP; Kunst H; Devilee P; Cremers CW; Schiffman JD; Bentz BG; Gygi SP; Winge DR; Kremer H; Rutter J
Science; 2009 Aug; 325(5944):1139-42. PubMed ID: 19628817
[TBL] [Abstract][Full Text] [Related]
17. SDHA is a tumor suppressor gene causing paraganglioma.
Burnichon N; Brière JJ; Libé R; Vescovo L; Rivière J; Tissier F; Jouanno E; Jeunemaitre X; Bénit P; Tzagoloff A; Rustin P; Bertherat J; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2010 Aug; 19(15):3011-20. PubMed ID: 20484225
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic and metabolic reprogramming of SDH-deficient paragangliomas.
Moog S; Lussey-Lepoutre C; Favier J
Endocr Relat Cancer; 2020 Dec; 27(12):R451-R463. PubMed ID: 33112834
[TBL] [Abstract][Full Text] [Related]
19. SDHi fungicides: An example of mitotoxic pesticides targeting the succinate dehydrogenase complex.
Duarte Hospital C; Tête A; Debizet K; Imler J; Tomkiewicz-Raulet C; Blanc EB; Barouki R; Coumoul X; Bortoli S
Environ Int; 2023 Oct; 180():108219. PubMed ID: 37778286
[TBL] [Abstract][Full Text] [Related]
20. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.
Bayley JP; Devilee P; Taschner PE
BMC Med Genet; 2005 Nov; 6():39. PubMed ID: 16288654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
